Miconazole%25252525252525252520vaginal%25252525252525252520pessary

# Miconazole Vaginal Pessary ## Overview Miconazole is an imidazole antifungal that inhibits the synthesis of ergosterol, a crucial component of fungal cell membranes, leading to increased membrane permeability and cell death. Vaginal formulations are available as over-the-counter (OTC) suppository inserts. ## Primary Indications * Vulvovaginal candidiasis (yeast infection). ## Adult Dosing * **100 mg suppository:** Insert 1 suppository intravaginally at bedtime for 7 consecutive days. * **200 mg suppository:** Insert 1 suppository intravaginally at bedtime for 3 consecutive days. * **1200 mg suppository (Ovule):** Insert 1 suppository intravaginally one time at bedtime. ## Pediatric Dosing * **Adolescents (≥12 years):** Use same adult dosing. * **Children (<12 years):** Not recommended without clinical evaluation to confirm diagnosis and rule out complex cases or sexual abuse. ## Dose Adjustments * **Renal/Hepatic Impairment:** No systemic adjustment required due to minimal systemic absorption. * **Pregnancy:** Use with caution; topical therapy is generally preferred. Consult clinical guidelines/local obstetric protocols regarding duration of therapy (longer courses may be required). ## Contraindications * Hypersensitivity to miconazole or any component of the formulation. * Recurrent infections (>3 episodes in 12 months) without initial physician diagnosis. * Symptoms suggestive of pelvic inflammatory disease (PID), fever, or severe pelvic pain. ## Adverse Effects * Local application site reactions: Vaginal burning, itching, irritation, or soreness. * Abdominal cramping or pelvic pain. * Headache. ## Key Drug Interactions * **Warfarin:** While systemic absorption is low, caution is advised. There have been reports of increased INR/bleeding risk with concurrent use of vaginal miconazole and warfarin. Monitor INR if used. ## Monitoring * Resolution of symptoms (itching, discharge, irritation). * If symptoms persist after completion of therapy or recur within 2 months, patient should seek medical evaluation to rule out other pathogens (e.g., bacterial vaginosis, trichomoniasis). ## Clinical Pearls * **Administration:** Pessary should be inserted high into the vagina using the provided applicator or fingers. * **Sexual Activity:** Miconazole may weaken latex or rubber products (condoms, diaphragms); avoid vaginal intercourse during treatment and for 72 hours post-treatment. * **Hygiene:** Advise patients to wear cotton underwear and avoid douching or using feminine sprays during treatment. * **Menstruation:** Use can continue during menstruation, but wait until it ends if using a product that requires a multi-day course if preferred, though clinical efficacy is generally maintained. *** *Disclaimer: This information is for educational purposes and is not a substitute for professional medical judgment. Always verify current prescribing information, institutional protocols, and patient-specific factors before administration.*